Scleritis market developments driving growth

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Anticipated Rise In Market Value Of The Scleritis Market During The Forecast Period?

The scleritis market size has shown significant expansion in recent years. It is projected to increase from $3.93 billion in 2025 to $4.28 billion in 2026, advancing at a compound annual growth rate (CAGR) of 8.9%. This historical growth can be ascribed to an increase in the prevalence of autoimmune disorders, the application of corticosteroids in ocular therapy, the accessibility of immunosuppressive agents, an expanding number of ophthalmology clinics, and a greater awareness of ocular inflammatory diseases.

The scleritis market size is anticipated to undergo significant expansion over the forthcoming years, with projections indicating it will reach $5.95 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 8.6%. This expected growth within the forecast period is attributable to several factors, including the availability of biologic drugs in the pipeline for ocular inflammation, the increasing adoption of teleophthalmology platforms, advancements in targeted anti-inflammatory therapies, improved access to sophisticated imaging techniques, and the wider reach of rare eye disease awareness programs. Prominent trends throughout this period encompass the broader application of biologic therapies for ocular inflammation, an uptick in the use of corticosteroids and immunosuppressive agents, the increasing embrace of combination therapy approaches, a heightened emphasis on early detection and diagnostic imaging, and the creation of innovative anti-inflammatory ophthalmic drugs.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21283&type=smp

Which Major Drivers Are Influencing The Expansion Of The Scleritis Market?

An increasing incidence of autoimmune conditions is anticipated to fuel expansion within the scleritis market. These diseases involve the body’s immune system erroneously targeting its own healthy cells and tissues, perceiving them as threats. The increase in autoimmune diseases is associated with genetic factors, environmental influences, shifts in lifestyle, and improved awareness, resulting in more accurate diagnoses. Autoimmune conditions contribute to scleritis by initiating an inflammatory immune reaction that incorrectly targets the scleral tissue, causing discomfort and redness. For instance, Public Health Scotland, a national organization based in Scotland, reported in August 2024 that the Scottish Multiple Sclerosis Register (SMSR) documented 455 newly diagnosed MS patients during 2023. Consequently, the growing occurrence of autoimmune diseases is propelling the expansion of the scleritis market.

Which Segment Categories Are Included In The Scleritis Market Segment Analysis?

The scleritis market covered in this report is segmented –

1) By Type: Anterior Scleritis, Posterior Scleritis, Other Types

2) By Treatment: Medication, Surgery, Other Treatment

3) By Distribution Channel: Direct Tender, Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channel

4) By End-Users: Hospitals, Specialty Clinics, Home Healthcare, Other End-Users

Subsegments:

1) By Anterior Scleritis: Non-Necrotizing Anterior Scleritis, Necrotizing Anterior Scleritis

2) By Posterior Scleritis: Diffuse Posterior Scleritis, Nodular Posterior Scleritis, Scleritis With Choroidal Involvement

3) By Other Types: Chronic Scleritis, Recurrent Scleritis, Infectious Scleritis

Which Trends Are Shaping The Scleritis Market?

Major companies operating in the scleritis market are concentrating on creating sophisticated products, such as eye drops, to tackle underlying inflammation and offer effective, non-invasive treatment options for patients. Eye drops are liquid preparations made for direct application to the eyes to manage conditions including irritation, dryness, inflammation, or infections. For instance, in May 2023, Entod Pharmaceuticals, an India-based pharmaceutical company, introduced CYCLOTEARS eye drops across India and globally. This novel therapy for inflammatory eye disease utilized proprietary SEDDS technology. This product improves drug delivery and effectiveness, providing a pioneering method to address inflammation in DED. This innovation marks a notable advancement in eye inflammatory treatment, ocular myositis, and scleritis.

Who Are The Active Companies Shaping The Scleritis Market?

Major companies operating in the scleritis market are Pfizer Inc, Johnson And Johnson, F Hoffmann La Roche Ltd, Bayer AG, Novartis AG, Teva Pharmaceuticals USA Inc, Baxter International Inc, Boehringer Ingelheim, Regeneron Pharmaceuticals Inc, Fresenius Kabi USA LLC, Sun Pharmaceutical Industries Ltd, Perrigo Company, Horizon Therapeutics plc, Aurobindo Pharma Ltd, Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC, Mallinckrodt Pharmaceuticals, Alvogen, Accord Healthcare, West Ward Pharmaceuticals, Jubilant Cadista Pharmaceuticals Inc, Mylan Pharmaceuticals Inc, Zydus Pharmaceuticals Inc

Get The Full Scleritis Market Report:

https://www.thebusinessresearchcompany.com/report/scleritis-global-market-report

Which Region Dominates The Scleritis Market By Market Share?

North America was the largest region in the scleritis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the scleritis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Scleritis Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/scleritis-global-market-report

Browse Through More Reports Similar to the Global Scleritis Market 2026, By The Business Research Company

Dermatitis Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/dermatitis-drugs-global-market-report

Knee Bursitis Market Report

https://www.thebusinessresearchcompany.com/report/knee-bursitis-global-market-report

Bacterial Conjunctivitis Market Report

https://www.thebusinessresearchcompany.com/report/bacterial-conjunctivitis-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795